PACT - Public Activities Coordination Tool
PACT - Public Activities Coordination Tool
PACT - Public Activities Coordination Tool
The public activities coordination tool (PACT) provides an overview of the substance-specific activities that authorities are working on under REACH and the CLP Regulation. These activities are being carried out in line with ECHA’s Integrated Regulatory Strategy.
PACT provides up-to-date information on the activities planned, ongoing or completed by ECHA and/or MSCAs for a given substance in the following areas:
- Data generation and assessment – dossier evaluation, substance evaluation, informal hazard assessment (PBT/vPvB/ED).
- Assessment of regulatory needs (ARN).
- Regulatory risk management – harmonised classification and labelling (CLH) , SVHC identification, recommendations for inclusion in the Authorisation List, restriction.
A summary of all the substance-specific activities can be found under ‘Details’ for each entry.
Further information
- Understanding PACT
- Integrated Regulatory Strategy
- Substances of potential concern
- Dossier Evaluation status
- Substance evaluation
- Endocrine disruptor assessment
- PBT assessment
- Assessment of regulatory needs list
- Registry of CLH intentions until outcome
- Registry of SVHC intentions until outcome
- Recommendations for inclusion in the Authorisation list
- Registry of restriction intentions until outcome
Filter the list
The List does not contain any Substances.
| Data generation and assessment | ARN | Regulatory risk management | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fosthiazate | 619-377-3 | 98886-44-3 | - | - | - | - | - | 2 | - | - | - | Details |
| Formaldehyde | 200-001-8 | 50-00-0 | 1 | - | 1 | - | 1 | 2 | - | - | - | Details |
| flumioxazin (ISO); N-(7-fluoro-3,4-dihydro-3-oxo-4-prop-2-ynyl-2H-1,4-benzoxazin-6-yl)cyclohex-1-ene-1,2-dicarboximide | 600-425-7 | 103361-09-7 | - | - | - | - | - | 2 | - | - | - | Details |
| Flonicamid (IKI-220) | 605-127-0 | 158062-67-0 | - | - | - | - | - | 2 | - | - | - | Details |
| Eugenol | 202-589-1 | 97-53-0 | - | - | - | - | - | 2 | - | - | - | Details |
| e-glass microfibres of representative composition | - | - | - | - | - | - | - | 2 | - | - | - | Details |
| Disodium octaborate | 234-541-0 | 12008-41-2 | - | - | - | - | 1 | 2 | 1 | 1 | - | Details |
| Diphenyl(2,4,6-trimethylbenzoyl)phosphine oxide | 278-355-8 | 75980-60-8 | 1 | 1 | 2 | - | 2 | 2 | 1 | 1 | - | Details |
| dinotefuran (ISO); 1-methyl-2-nitro-3-(tetrahydro-3-furylmethyl)guanidine | 605-399-0 | 165252-70-0 | - | - | - | 1 | - | 2 | - | - | - | Details |
| Dichlofluanid | 214-118-7 | 1085-98-9 | - | - | - | - | - | 2 | - | - | - | Details |
| Diammonium decaborate | 234-521-1 | 12007-89-5 | - | - | - | - | - | 2 | - | - | - | Details |
| cymoxanil (ISO); 2-cyano-N-[(ethylamino)carbonyl]-2-(methoxyimino)acetamide | 261-043-0 | 57966-95-7 | - | - | - | - | - | 2 | - | - | - | Details |
| Copper | 231-159-6 | 7440-50-8 | - | - | 1 | 1 | - | 2 | - | - | - | Details |
| Clethodim | 619-396-7 | 99129-21-2 | - | - | - | - | - | 2 | - | - | - | Details |
| Cinnamaldehyde | 203-213-9 | 104-55-2 | - | - | 2 | - | - | 2 | - | - | - | Details |
|
Chrysanthemum cinerariaefolium, ext.
Extractives and their physically modified derivatives such as tinctures, concretes, absolutes, essential oils, oleoresins, terpenes, terpene-free fractions, distillates, residues, etc., obtained from Chrysanthemum cinerariaefolium, Compositae.
|
289-699-3 | 89997-63-7 | - | - | - | 2 | - | 2 | - | - | - | Details |
| Biphenyl-2-ol | 201-993-5 | 90-43-7 | - | - | - | - | - | 2 | - | - | - | Details |
| 4-tert-butylphenol | 202-679-0 | 98-54-4 | 1 | - | 1 | 1 | 3 | 2 | 1 | - | - | Details |
| 4-tert-butylbenzoic acid | 202-696-3 | 98-73-7 | - | - | - | - | 1 | 2 | - | - | - | Details |
| 4,4'-isopropylidenediphenol | 201-245-8 | 80-05-7 | 1 | - | 1 | 2 | 3 | 2 | 3 | 1 | 2 | Details |
| 3-iodo-2-propynyl butylcarbamate | 259-627-5 | 55406-53-6 | - | - | - | 1 | - | 2 | - | - | - | Details |
| 3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluorodecan-1-ol | 211-648-0 | 678-39-7 | - | - | - | - | - | 2 | - | - | - | Details |
| 2-ethylhexyl 10-ethyl-4,4-dioctyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoate | 239-622-4 | 15571-58-1 | - | - | 2 | - | 1 | 2 | 1 | 1 | - | Details |
|
2-benzyl-2-dimethylamino-4'-morpholinobutyrophenone
CG 25-369; IRGACURE 369; TK 11-319
|
404-360-3 | 119313-12-1 | - | - | 11 | - | 2 | 2 | 1 | 1 | - | Details |
| 2,4,6,8-tetramethyl-1,3,5,7-tetraoxacyclooctane | 203-600-2 | 108-62-3 | - | - | - | - | - | 2 | - | - | - | Details |